PBRM1 and neoplasm: The tumor lineage and aggressive potential was confirmed by extensive genetic testing revealing a high tumor mutational burden and pathogenic mutations in TERT, NRAS, and NF1, alongside alterations in PBRM1 and FAT1, which may contribute to the tumor's unique morphology.